Holen Sie sich die Stockscreener-App
1.41
0.70%
-0.01
Silexion Therapeutics Corp Aktie (SLXN) Neueste Nachrichten
Silexion Therapeutics Announces Immediate Board Membership Change - TipRanks
Ilan Levin removed from Silexion Therapeutics board - TradingView
Board at Silexion Therapeutics (NASDAQ: SLXN) removes Ilan Levin - Stock Titan
Is Silexion Therapeutics Corp a strong growth stockMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Silexion Therapeutics approved to initiate Phase 2/3 clinical trial of SIL204 - TipRanks
Silexion Shareholders Reject Capital Increase and Plan Amendments - The Globe and Mail
Silexion Therapeutics Receives Israeli Ministry of Health Approval for Phase 2/3 Clinical Trial of SIL204 in Advanced Pancreatic Cancer - Minichart
Silexion gets Israeli approval for pancreatic cancer trial - Investing.com
Silexion Therapeutics Receives Approval from Israeli - GlobeNewswire
Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer - Yahoo! Finance Canada
Silexion gains approval for SIL204 pancreatic cancer trial - TipRanks
Silexion Granted Approval to Launch Human Trials That Could Redefine the Future of Cancer Treatment - Benzinga
Regulators clear Silexion (NASDAQ: SLXN) to begin SIL204 pancreatic cancer trial - Stock Titan
Silexion receives Israeli approval for pancreatic cancer trial - Investing.com
Pancreatic cancer drug SIL204 gets Israel approval for human trial - Stock Titan
Silexion Therapeutics Corp 8-K Filing – Share Capital Increase Proposal Not Approved (March 2026) - Minichart
Silexion Therapeutics Corp announced plans to submit its Phase 2/3 clinical trial application to German regulators by the end of this quarter. - Bitget
Silexion Therapeutics shareholders reject share capital and equity plan increases By Investing.com - Investing.com South Africa
Shareholders at Silexion (SLXN) vote down capital and evergreen increase proposals - Stock Titan
Growth Report: Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soon2026 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
EPS Watch: Can Silexion Therapeutics Corp Equity Warrant expand its profit margins2026 Snapshot & Fast Moving Trade Plans - baoquankhu1.vn
Form 8K Silexion Therapeutics Corp For: 3 February - Investing.com
Maxim Group Maintains Silexion Therapeutics(SLXN.US) With Buy Rating, Maintains Target Price $6 - 富途牛牛
Tangible book value per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
SLXNW Financials: Income Statement, Balance Sheet & Cash Flow | Silexion Therapeutics Corp - Stock Titan
Silexion Therapeutics Corp: Clinical-Stage KRAS Oncology Innovations and siRNA Pipeline for Pancreatic Cancer - Minichart
Silexion Therapeutics Reports 2025 Financial Results and Clinical Program Updates - geneonline.com
Biotech Silexion lines up 2026 pancreatic cancer trial after $18.6M cash raise - Stock Titan
Silexion Therapeutics 10-K: $11.9M net loss, cash $6.08M; operating loss $11.63M - TradingView
Silexion Therapeutics (NASDAQ: SLXN) outlines SIL204 KRAS cancer strategy in 10-K - Stock Titan
Silexion Therapeutics Corp Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Growth Recap: Is Silexion Therapeutics Corp Equity Warrant a potential multi baggerTrade Volume Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Setup Watch: Can Silexion Therapeutics Corp Equity Warrant stock outperform in a bear marketBreakout Watch & Entry Point Confirmation Signals - baoquankhu1.vn
Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewswire
Silexion Therapeutics Corp Auditor Raises 'Going Concern' Doubt - marketscreener.com
SLXN SEC FilingsSilexion Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: MetaVia (MTVA), Immunome (IMNM) - The Globe and Mail
Fed Meeting: Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonQuarterly Profit Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
Silexion Therapeutics Urges Shareholders to Vote Ahead of March 16 Extraordinary General Meeting - Bitget
Cancer biotech Silexion seeks to authorize 50M more shares - Stock Titan
Rally Mode: Is Silexion Therapeutics Corp a defensive stock2025 Price Targets & Entry and Exit Point Strategies - baoquankhu1.vn
SLXN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Book value per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
EPS Watch: Is First Light Acquisition Group Inc Equity Warrant vulnerable to short sellersQuarterly Portfolio Report & Smart Allocation Stock Tips - baoquankhu1.vn
SLXN Should I Buy - Intellectia AI
EBITDA per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
Market Fear: Should value investors consider CompoSecure Inc Equity WarrantMarket Activity Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Equity grants to director-linked fund at Silexion Therapeutics (SLXN) disclosed - Stock Titan
Director Alon Ruth receives Silexion (SLXN) share and stock option grants - Stock Titan
Silexion Therapeutics (SLXN) CFO receives 49,726-share equity grant - Stock Titan
Silexion (SLXN) CEO Hadar Ilan receives 64,350-share equity award - Stock Titan
Director at Silexion Therapeutics (SLXN) receives new share and option grants - Stock Titan
Silexion Therapeutics (SLXN) director granted 7,576 shares and 8,904 options - Stock Titan
Guangzhou Sino-Israel Biotech Fund gains SLXN equity for board service - Stock Titan
Ideas Watch: Is Olympic Steel Inc forming a breakout patternOptions Play & Weekly High Conviction Trade Ideas - baoquankhu1.vn
SLXNSilexion Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
Will Silexion Therapeutics Corp benefit from geopolitical trendsDip Buying & AI Powered Buy/Sell Recommendations - mfd.ru
Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonWeekly Trend Recap & Expert Verified Movement Alerts - mfd.ru
Price Action: How volatile is Silexion Therapeutics Corp stockBull Run & Weekly Return Optimization Plans - baoquankhu1.vn
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN) By FinanceWire - Investing.com
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN) - TipRanks
Stock Report: Is Silexion Therapeutics Corp Equity Warrant stock forming a triangle patternWall Street Watch & Community Shared Stock Ideas - mfd.ru
Can Silexion Therapeutics Corp Equity Warrant stock deliver strong Q4 earningsQuarterly Portfolio Report & AI Enhanced Market Trend Forecasts - mfd.ru
S P Trends: Will CIMPRD benefit from rate cuts2025 Price Momentum & Daily Price Action Insights - baoquankhu1.vn
Momentum Shift: Should I hold or sell Silexion Therapeutics Corp now2025 Trading Volume Trends & Fast Gain Swing Alerts - baoquankhu1.vn
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):